Literature DB >> 16460502

Rectal malignant lymphoma complicating ulcerative colitis treated with long-term cyclosporine A.

Takeshi Shibahara, Kaori Miyazaki, Daisuke Sato, Hirohumi Matsui, Akinori Yanaka, Akira Nakahara, Naomi Tanaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460502     DOI: 10.1111/j.1440-1746.2006.03988.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  5 in total

Review 1.  Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.

Authors:  Meenakshi Bewtra; James D Lewis
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

2.  The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis.

Authors:  B Bressler; J K Law; N Al Nahdi Sheraisher; K Atkinson; M F Byrne; H V Chung; M Fishman; N Partovi; D Pearson; R Penner; R A Enns
Journal:  Can J Gastroenterol       Date:  2008-11       Impact factor: 3.522

3.  Primary rectal diffuse large B-cell lymphoma associated with ulcerative colitis: a case report.

Authors:  Kazuhiro Hiyama; Hideo Terashima; Yoritaka Nakano; Masahiro Kamiga; Kyoichi Harada; Hisashi Horiguchi; Takashi Mamiya
Journal:  Clin Case Rep       Date:  2014-12-04

4.  Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy.

Authors:  Masahiro Ohara; Kokoro Ozaki; Takuya Ohkubo; Akane Yamada; Yoshiyuki Numasawa; Keisuke Tanaka; Shohei Tomii; Satoru Ishibashi; Nobuo Sanjo; Takanori Yokota
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

5.  A case of iatrogenic immunodeficiency-associated colonic lymphoma complicating ulcerative colitis.

Authors:  Kazushi Suzuki; Rintaro Ohe; Takanobu Kabasawa; Naing Ye Aung; Mitsuhiro Yano; Shuichiro Katsumi; Ryo Yanagiya; Masakazu Yamamoto; Tomomi Toubai; Kenichi Ishizawa; Mitsunori Yamakawa
Journal:  Diagn Pathol       Date:  2020-04-07       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.